Literature DB >> 35441932

A third high dose of inactivated COVID-19 vaccine induces higher neutralizing antibodies in humans against the Delta and Omicron variants: a Randomized, Double-Blinded Clinical Trial.

Yu Cao1, Xiaoli Wang2, Siqi Li2, Yuan Dong1, Yonghong Liu2, Jing Li3, Yanqing Zhao3, Yingmei Feng4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35441932      PMCID: PMC9020148          DOI: 10.1007/s11427-022-2110-1

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN: 1674-7305            Impact factor:   10.372


× No keyword cloud information.
  8 in total

1.  Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines.

Authors:  Yunlong Cao; Ayijiang Yisimayi; Yali Bai; Weijin Huang; Xiaofeng Li; Zhiying Zhang; Tianjiao Yuan; Ran An; Jing Wang; Tianhe Xiao; Shuo Du; Wenping Ma; Liyang Song; Yongzheng Li; Xiang Li; Weiliang Song; Jiajing Wu; Shuo Liu; Xuemei Li; Yonghong Zhang; Bin Su; Xianghua Guo; Yangyang Wei; Chuanping Gao; Nana Zhang; Yifei Zhang; Yang Dou; Xiaoyu Xu; Rui Shi; Bai Lu; Ronghua Jin; Yingmin Ma; Chengfeng Qin; Youchun Wang; Yingmei Feng; Junyu Xiao; Xiaoliang Sunney Xie
Journal:  Cell Res       Date:  2021-05-21       Impact factor: 25.617

2.  Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization.

Authors:  Sandile Cele; Laurelle Jackson; David S Khoury; Khadija Khan; Thandeka Moyo-Gwete; Houriiyah Tegally; James Emmanuel San; Deborah Cromer; Cathrine Scheepers; Daniel G Amoako; Farina Karim; Mallory Bernstein; Gila Lustig; Derseree Archary; Muneerah Smith; Yashica Ganga; Zesuliwe Jule; Kajal Reedoy; Shi-Hsia Hwa; Jennifer Giandhari; Jonathan M Blackburn; Bernadett I Gosnell; Salim S Abdool Karim; Willem Hanekom; Anne von Gottberg; Jinal N Bhiman; Richard J Lessells; Mahomed-Yunus S Moosa; Miles P Davenport; Tulio de Oliveira; Penny L Moore; Alex Sigal
Journal:  Nature       Date:  2021-12-23       Impact factor: 49.962

3.  Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies.

Authors:  Xun Wang; Xiaoyu Zhao; Jieyu Song; Jing Wu; Yuqi Zhu; Minghui Li; Yuchen Cui; Yanjia Chen; Lulu Yang; Jun Liu; Huanzhang Zhu; Shibo Jiang; Pengfei Wang
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 7.163

4.  Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study.

Authors:  Adam S Lauring; Mark W Tenforde; James D Chappell; Manjusha Gaglani; Adit A Ginde; Tresa McNeal; Shekhar Ghamande; David J Douin; H Keipp Talbot; Jonathan D Casey; Nicholas M Mohr; Anne Zepeski; Nathan I Shapiro; Kevin W Gibbs; D Clark Files; David N Hager; Arber Shehu; Matthew E Prekker; Heidi L Erickson; Matthew C Exline; Michelle N Gong; Amira Mohamed; Nicholas J Johnson; Vasisht Srinivasan; Jay S Steingrub; Ithan D Peltan; Samuel M Brown; Emily T Martin; Arnold S Monto; Akram Khan; Catherine L Hough; Laurence W Busse; Caitlin C Ten Lohuis; Abhijit Duggal; Jennifer G Wilson; Alexandra June Gordon; Nida Qadir; Steven Y Chang; Christopher Mallow; Carolina Rivas; Hilary M Babcock; Jennie H Kwon; Natasha Halasa; Carlos G Grijalva; Todd W Rice; William B Stubblefield; Adrienne Baughman; Kelsey N Womack; Jillian P Rhoads; Christopher J Lindsell; Kimberly W Hart; Yuwei Zhu; Katherine Adams; Stephanie J Schrag; Samantha M Olson; Miwako Kobayashi; Jennifer R Verani; Manish M Patel; Wesley H Self
Journal:  BMJ       Date:  2022-03-09

5.  Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants.

Authors:  Kang Wang; Zijing Jia; Linilin Bao; Lei Wang; Lei Cao; Hang Chi; Yaling Hu; Qianqian Li; Yunjiao Zhou; Yinan Jiang; Qianhui Zhu; Yongqiang Deng; Pan Liu; Nan Wang; Lin Wang; Min Liu; Yurong Li; Boling Zhu; Kaiyue Fan; Wangjun Fu; Peng Yang; Xinran Pei; Zhen Cui; Lili Qin; Pingju Ge; Jiajing Wu; Shuo Liu; Yiding Chen; Weijin Huang; Qiao Wang; Cheng-Feng Qin; Youchun Wang; Chuan Qin; Xiangxi Wang
Journal:  Nature       Date:  2022-01-28       Impact factor: 49.962

6.  Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials.

Authors:  Gang Zeng; Qianhui Wu; Hongxing Pan; Minjie Li; Juan Yang; Lin Wang; Zhiwei Wu; Deyu Jiang; Xiaowei Deng; Kai Chu; Wen Zheng; Lei Wang; Wanying Lu; Bihua Han; Yuliang Zhao; Fengcai Zhu; Hongjie Yu; Weidong Yin
Journal:  Lancet Infect Dis       Date:  2021-12-08       Impact factor: 71.421

7.  Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa.

Authors:  Juliet R C Pulliam; Cari van Schalkwyk; Nevashan Govender; Anne von Gottberg; Cheryl Cohen; Michelle J Groome; Jonathan Dushoff; Koleka Mlisana; Harry Moultrie
Journal:  Science       Date:  2022-05-06       Impact factor: 63.714

8.  Neutralizing antibody activity against 21 SARS-CoV-2 variants in older adults vaccinated with BNT162b2.

Authors:  Joseph Newman; Nazia Thakur; Thomas P Peacock; Dagmara Bialy; Ahmed M E Elrefaey; Carlijn Bogaardt; Daniel L Horton; Sammy Ho; Thivya Kankeyan; Christine Carr; Katja Hoschler; Wendy S Barclay; Gayatri Amirthalingam; Kevin E Brown; Bryan Charleston; Dalan Bailey
Journal:  Nat Microbiol       Date:  2022-07-14       Impact factor: 30.964

  8 in total
  1 in total

1.  An antibody cocktail with broadened mutational resistance and effective protection against SARS-CoV-2.

Authors:  Chunyun Sun; Hang Chi; Fei Yuan; Jing Li; Ji Yang; Aihua Zheng; Fei Wang; Lingling Sun; Yanjing Zhang; Ping Hu; Lihua Jiao; Yongqiang Deng; Liangzhi Xie
Journal:  Sci China Life Sci       Date:  2022-09-29       Impact factor: 10.372

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.